1. Home
  2. GNLX vs ALAR Comparison

GNLX vs ALAR Comparison

Compare GNLX & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • ALAR
  • Stock Information
  • Founded
  • GNLX 2001
  • ALAR 2013
  • Country
  • GNLX United States
  • ALAR Israel
  • Employees
  • GNLX N/A
  • ALAR N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • GNLX Health Care
  • ALAR Technology
  • Exchange
  • GNLX Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • GNLX 128.0M
  • ALAR 103.6M
  • IPO Year
  • GNLX 2023
  • ALAR 2018
  • Fundamental
  • Price
  • GNLX $7.70
  • ALAR $15.81
  • Analyst Decision
  • GNLX Strong Buy
  • ALAR Strong Buy
  • Analyst Count
  • GNLX 5
  • ALAR 1
  • Target Price
  • GNLX $17.40
  • ALAR $27.00
  • AVG Volume (30 Days)
  • GNLX 232.9K
  • ALAR 55.4K
  • Earning Date
  • GNLX 11-13-2025
  • ALAR 11-24-2025
  • Dividend Yield
  • GNLX N/A
  • ALAR N/A
  • EPS Growth
  • GNLX N/A
  • ALAR N/A
  • EPS
  • GNLX N/A
  • ALAR 0.07
  • Revenue
  • GNLX N/A
  • ALAR $30,488,000.00
  • Revenue This Year
  • GNLX N/A
  • ALAR $28.77
  • Revenue Next Year
  • GNLX N/A
  • ALAR $31.83
  • P/E Ratio
  • GNLX N/A
  • ALAR $21.38
  • Revenue Growth
  • GNLX N/A
  • ALAR N/A
  • 52 Week Low
  • GNLX $1.99
  • ALAR $5.45
  • 52 Week High
  • GNLX $8.27
  • ALAR $18.00
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 73.82
  • ALAR 57.69
  • Support Level
  • GNLX $7.05
  • ALAR $13.50
  • Resistance Level
  • GNLX $8.26
  • ALAR $15.75
  • Average True Range (ATR)
  • GNLX 0.68
  • ALAR 0.81
  • MACD
  • GNLX 0.17
  • ALAR 0.12
  • Stochastic Oscillator
  • GNLX 82.75
  • ALAR 85.87

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

Share on Social Networks: